Success Metrics

Clinical Success Rate

100.0%

Based on 1 completed trials

Completion Rate

100%(1/1)

Active Trials

4(50%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_1

13%

Ph phase_3

38%

Ph phase_2

38%

Ph phase_4

13%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution8 total trials

Phase 1Safety & dosage

1(12.5%)

Phase 2Efficacy & side effects

3(37.5%)

Phase 3Large-scale testing

3(37.5%)

Phase 4Post-market surveillance

1(12.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(7)

Completed(1)

Detailed Status

Recruiting4

Not yet recruiting3

Completed1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 11 (12.5%)

Phase 23 (37.5%)

Phase 33 (37.5%)

Phase 41 (12.5%)

Trials by Status

recruiting450%

completed113%

not_yet_recruiting338%

Recent Activity

4 active trials

Showing 5 of 8

recruitingphase_3

Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB

NCT06114628

not_yet_recruitingphase_3

Optimal Treatment Duration for Radiographically Apparent, Bacteriologically Unconfirmed TB, Identified Through Active Case Finding (RADIO-TB Trial)

NCT07163143

View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials

NCT06905522Phase 3

A PAN-USR TB Multi-Center Trial

Recruiting

NCT07213765Phase 4

Short-term Antibiotic Therapy in Mycobacterium Avium Complex Pulmonary Disease

PanACEA - STEP2C -01

Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB

Recruiting

NCT07163143Phase 3

Optimal Treatment Duration for Radiographically Apparent, Bacteriologically Unconfirmed TB, Identified Through Active Case Finding (RADIO-TB Trial)

Not Yet Recruiting

NCT07129629Phase 2

Short-Course Regimen With Bedaquiline, Moxifloxacin and Pyrazinamide for Early Bactericidal Activity in Drug-Susceptible Tuberculosis

Not Yet Recruiting

NCT07076225Phase 3

Ultra-Short Regimen for Elderly DS-TB

Not Yet Recruiting

NCT02457208Phase 1

PK Study of Anti-TB Drugs

Completed

All 8 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 8